Fund shareholders of Editas Medicine Inc
ISIN US28106W1036 · United States · LEI 5299000AON4Q9NT2JE42
- Fund shareholders
- 132
- Of which ETFs
- 20 112 other funds
- Value held
- ≈ 49.2M $ 49.2M $ · 36.7K €
- Share of capital
- 12.7 % of 153.6M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| ProShares UltraPro Russell2000 ProShares Trust | 5,548 | 12.2K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 5,197 | 11.4K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 4,508 | 9.9K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 4,341 | 10.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 3,926 | 8.6K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Small Company Value Portfolio Wilshire Mutual Funds Inc | 3,582 | 8.8K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 3,408 | 10.2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 3,341 | 10K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 3,076 | 6.8K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 3,056 | 7.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 2,959 | 6.5K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 2,530 | 6.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 2,500 | 6.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 2,285 | 5.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 2,042 | 5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,688 | 4.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 1,580 | 3.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Motley Fool Next Index ETF RBB Fund, Inc. | 1,354 | 3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,113 | 3.3K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 1,103 | 2.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 524 | 1.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 430 | 1.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 329 | 812.6 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 249 | 615 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 198 | 489.1 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 180 | 540 $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 118 | 291.5 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 93 | 204.6 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 89 | 219.8 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 27 | 59.4 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 22 | 54.3 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TOP CLASS HEALTHCARE, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 36.7K € | 0.27 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| WisdomTree BioRevolution Fund WisdomTree Trust | 0.89 % | as of Mar 31, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.43 % | as of Feb 28, 2026 ↗ |
| Horizon Kinetics Medical ETF Listed Funds Trust | 0.39 % | as of Mar 31, 2026 ↗ |
| AXS Green Alpha ETF INVESTMENT MANAGERS SERIES TRUST II | 0.37 % | as of Mar 31, 2026 ↗ |
| TOP CLASS HEALTHCARE, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 0.27 % | as of Dec 31, 2025 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.25 % | as of Mar 31, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 0.20 % | as of Feb 28, 2026 ↗ |
| Nuveen Quant Small Cap Equity Fund TIAA-CREF Funds | 0.13 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Small Cap Equity Fund TIAA-CREF Life Funds | 0.12 % | as of Mar 31, 2026 ↗ |
| NVIT Small Cap Value Fund Nationwide Variable Insurance Trust | 0.12 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 131 | +2 | 19,462,276 | +3.6 % |
| 2026Q1 | 129 | -6 | 18,778,765 | +11.1 % |
| 2025Q4 | 135 | +12 | 16,908,592 | -2.9 % |
| 2025Q3 | 123 | -3 | 17,413,380 | +5.2 % |
| 2025Q2 | 126 | -28 | 16,559,777 | -6.8 % |
| 2025Q1 | 154 | -14 | 17,768,142 | -3.1 % |
| 2024Q4 | 168 | -6 | 18,341,240 | -16.9 % |
| 2024Q3 | 174 | -12 | 22,079,275 | -23.9 % |
| 2024Q2 | 186 | +14 | 29,010,980 | +21.5 % |
| 2024Q1 | 172 | +5 | 23,870,324 | +2.6 % |
| 2023Q4 | 167 | 23,266,485 |
Institutional managers
199 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 9,263,312 | 22.9M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 3,972,160 | 9.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,311,789 | 5.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,076,122 | 5.1M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 1,977,509 | 4.9M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 1,947,384 | 4.3M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,943,893 | 4.8M $ | as of Mar 31, 2026 |
| Opaleye Management Inc. | 1,926,997 | 4.8M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,549,063 | 3.8M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 1,457,715 | 3.6K $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 1,370,497 | 3.4M $ | as of Mar 31, 2026 |
| RAYMOND JAMES FINANCIAL INC | 1,293,848 | 3.2M $ | as of Mar 31, 2026 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,052,457 | 2.6M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 861,326 | 2.1M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 742,443 | 1.8M $ | as of Mar 31, 2026 |
| MACKENZIE FINANCIAL CORP | 730,054 | 1.8M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 662,389 | 1.6M $ | as of Mar 31, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 582,309 | 1.4M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 558,577 | 1.4M $ | as of Mar 31, 2026 |
| GSA CAPITAL PARTNERS LLP | 434,413 | 1.1K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 411,192 | 1M $ | as of Mar 31, 2026 |
| UBS Group AG | 393,754 | 972.6K $ | as of Mar 31, 2026 |
| Susquehanna Portfolio Strategies, LLC | 332,933 | 822.3K $ | as of Mar 31, 2026 |
| Eversept Partners, LP | 290,919 | 718.6K $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 272,567 | 673.2K $ | as of Mar 31, 2026 |
Declared shareholders of Editas Medicine Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Commodore Capital LP and 3 others | 9.90 % | 16,045,802 | as of May 26, 2026 · SCHEDULE 13G |
| TCG Crossover GP III, LLC and 2 others | 9.90 % | 15,798,999 | as of May 27, 2026 · SCHEDULE 13G |
| RA Capital Management, L.P. and 3 others | 5.80 % | 8,889,000 | as of May 27, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Editas Medicine Inc". https://titelia.com/en/stocks/editas-medicine-inc-US28106W1036